Jessica Claussen, MD | |
625 N Foster St Ste 202, Mitchell, SD 57301-2903 | |
(605) 995-6393 | |
(605) 995-6392 |
Full Name | Jessica Claussen |
---|---|
Gender | Female |
Speciality | Ophthalmology |
Experience | 15 Years |
Location | 625 N Foster St Ste 202, Mitchell, South Dakota |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1700014412 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | 8818 (South Dakota) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Huron Regional Medical Center | Huron, SD | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Avera Queen Of Peace | 9335050806 | 84 |
News Archive
Doctors practicing IVF often transferred multiple embryos to a woman's body at once, in the hope that at least one of them would lead to a successful pregnancy. That changes now as a new study from researchers at the University of Iowa in Iowa City found that women who had only one embryo transferred during IVF didn't have lower chances of getting pregnant, but they did have a lower risk of giving birth to twins than women who had multiple embryos transferred.
Today, Veeva Systems announced that it has acquired Merqurio's healthcare professional (HCP) and healthcare organisation (HCO) database for Italy. With the acquisition of this market-leading Italian HCP and stakeholder data, Veeva OpenData now expands to a third major European market and builds on Veeva's commitment to deliver a new approach to customer reference data that is open, easy, and global.
Scientists are making strides in understanding how the malaria parasite Plasmodium falciparum disguises itself to avoid detection by the immune system. The findings could lead to the development of new drugs for a disease that causes more than 300 million acute illnesses and at least one million deaths each year, most of them in developing countries.
Insurance needs and health systems vary state to state, and experience tells us that the best way forward is not to mandate a one-size-fits-all answer. Instead, our approach gives states the flexibility to take their own paths, while ensuring they all end up in the best place possible: with an Affordable Insurance Exchange that offers access to comprehensive, quality, affordable health insurance to small business owners and individuals who currently have few good choices in an expensive and broken market.
Developing new drugs to treat cancer can be a painstaking process taking over a decade from start to Food and Drug Administration approval. Scientists are trying to develop innovative strategies to identify and test new drugs quicker and more efficiently.
› Verified 9 days ago
Entity Name | Avera Queen Of Peace |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1205359031 PECOS PAC ID: 9335050806 Enrollment ID: O20031229000301 |
News Archive
Doctors practicing IVF often transferred multiple embryos to a woman's body at once, in the hope that at least one of them would lead to a successful pregnancy. That changes now as a new study from researchers at the University of Iowa in Iowa City found that women who had only one embryo transferred during IVF didn't have lower chances of getting pregnant, but they did have a lower risk of giving birth to twins than women who had multiple embryos transferred.
Today, Veeva Systems announced that it has acquired Merqurio's healthcare professional (HCP) and healthcare organisation (HCO) database for Italy. With the acquisition of this market-leading Italian HCP and stakeholder data, Veeva OpenData now expands to a third major European market and builds on Veeva's commitment to deliver a new approach to customer reference data that is open, easy, and global.
Scientists are making strides in understanding how the malaria parasite Plasmodium falciparum disguises itself to avoid detection by the immune system. The findings could lead to the development of new drugs for a disease that causes more than 300 million acute illnesses and at least one million deaths each year, most of them in developing countries.
Insurance needs and health systems vary state to state, and experience tells us that the best way forward is not to mandate a one-size-fits-all answer. Instead, our approach gives states the flexibility to take their own paths, while ensuring they all end up in the best place possible: with an Affordable Insurance Exchange that offers access to comprehensive, quality, affordable health insurance to small business owners and individuals who currently have few good choices in an expensive and broken market.
Developing new drugs to treat cancer can be a painstaking process taking over a decade from start to Food and Drug Administration approval. Scientists are trying to develop innovative strategies to identify and test new drugs quicker and more efficiently.
› Verified 9 days ago
Entity Name | Avera Queen Of Peace |
---|---|
Entity Type | Part A Provider - Critical Access Hospital |
Entity Identifiers | NPI Number: 1992466635 PECOS PAC ID: 9335050806 Enrollment ID: O20220301001771 |
News Archive
Doctors practicing IVF often transferred multiple embryos to a woman's body at once, in the hope that at least one of them would lead to a successful pregnancy. That changes now as a new study from researchers at the University of Iowa in Iowa City found that women who had only one embryo transferred during IVF didn't have lower chances of getting pregnant, but they did have a lower risk of giving birth to twins than women who had multiple embryos transferred.
Today, Veeva Systems announced that it has acquired Merqurio's healthcare professional (HCP) and healthcare organisation (HCO) database for Italy. With the acquisition of this market-leading Italian HCP and stakeholder data, Veeva OpenData now expands to a third major European market and builds on Veeva's commitment to deliver a new approach to customer reference data that is open, easy, and global.
Scientists are making strides in understanding how the malaria parasite Plasmodium falciparum disguises itself to avoid detection by the immune system. The findings could lead to the development of new drugs for a disease that causes more than 300 million acute illnesses and at least one million deaths each year, most of them in developing countries.
Insurance needs and health systems vary state to state, and experience tells us that the best way forward is not to mandate a one-size-fits-all answer. Instead, our approach gives states the flexibility to take their own paths, while ensuring they all end up in the best place possible: with an Affordable Insurance Exchange that offers access to comprehensive, quality, affordable health insurance to small business owners and individuals who currently have few good choices in an expensive and broken market.
Developing new drugs to treat cancer can be a painstaking process taking over a decade from start to Food and Drug Administration approval. Scientists are trying to develop innovative strategies to identify and test new drugs quicker and more efficiently.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Jessica Claussen, MD 625 N Foster St Ste 202, Mitchell, SD 57301-2903 Ph: (605) 995-6393 | Jessica Claussen, MD 625 N Foster St Ste 202, Mitchell, SD 57301-2903 Ph: (605) 995-6393 |
News Archive
Doctors practicing IVF often transferred multiple embryos to a woman's body at once, in the hope that at least one of them would lead to a successful pregnancy. That changes now as a new study from researchers at the University of Iowa in Iowa City found that women who had only one embryo transferred during IVF didn't have lower chances of getting pregnant, but they did have a lower risk of giving birth to twins than women who had multiple embryos transferred.
Today, Veeva Systems announced that it has acquired Merqurio's healthcare professional (HCP) and healthcare organisation (HCO) database for Italy. With the acquisition of this market-leading Italian HCP and stakeholder data, Veeva OpenData now expands to a third major European market and builds on Veeva's commitment to deliver a new approach to customer reference data that is open, easy, and global.
Scientists are making strides in understanding how the malaria parasite Plasmodium falciparum disguises itself to avoid detection by the immune system. The findings could lead to the development of new drugs for a disease that causes more than 300 million acute illnesses and at least one million deaths each year, most of them in developing countries.
Insurance needs and health systems vary state to state, and experience tells us that the best way forward is not to mandate a one-size-fits-all answer. Instead, our approach gives states the flexibility to take their own paths, while ensuring they all end up in the best place possible: with an Affordable Insurance Exchange that offers access to comprehensive, quality, affordable health insurance to small business owners and individuals who currently have few good choices in an expensive and broken market.
Developing new drugs to treat cancer can be a painstaking process taking over a decade from start to Food and Drug Administration approval. Scientists are trying to develop innovative strategies to identify and test new drugs quicker and more efficiently.
› Verified 9 days ago
Dr. Ray T Birkenkamp, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 305 N Sanborn Blvd, Mitchell, SD 57301 Phone: 605-996-2537 Fax: 605-996-0500 | |
Dr. Filemon Evangelista Olegario, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 120 W 6th Ave, Mitchell, SD 57301 Phone: 606-996-9141 Fax: 605-996-9194 |